Sio Capital Management, LLC Portfolio
Auto-discovered 13F filer (Top-2000 by latest reported value).
SEC 13F CIK: 0001482416
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q2 2026 · 59 positions · Total reported value $604.29M · Top-10 concentration 48.6% · Updated 2026-10-24
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
Turnover: 77.2% · 16 new · 22 cut · 33 exited
Active Share (vs S&P 500): 99.1% · vs QQQ: 99.7% — share of the book that differs from index weights (higher = more active) · ranking
Est. Qtr Return (Q1 2026 → Q2 2026): +18.0% · vs SPY +3.2% · Prev Value $697.31M — last quarter positions weighted by this quarter price moves · ranking
In its Q2 2026 13F filing, Sio Capital Management, LLC disclosed 59 equity positions with a combined reported value of $604.29M. The filing implies a moderately concentrated portfolio: its ten largest positions account for 48.6% of reported value. HoldingsHub classifies the profile as Small / Health Tilt / High Turnover.
The largest disclosed positions as of Q2 2026 were AVR ($54.63M), COR ($49.12M), MMS ($38.45M). By sector, the heaviest allocations are Health Care 86.6%, Consumer Discretionary 6.4%. Versus the prior quarter, allocation shifted toward Health Care (+3.6pp) and away from Consumer Discretionary (-0.7pp), Technology (-2.5pp).
Versus the prior quarter, Sio Capital Management, LLC opened 16 new positions, trimmed 22 and fully exited 33, a turnover rate of 77.2% of positions. The portfolio's overlap with the prior quarter was 47% of names.
The largest new positions opened in Q2 2026 were ALLO ($27.71M), GMED ($23.85M), SLS ($18.17M).
Of the 33 positions fully exited versus the prior quarter, the largest were CORT ($27.20M), LIVN ($26.80M), EMBC ($16.33M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q2 2026)
Fully Exited (vs previous quarter)
- CORT CORCEPT THERAPEUTICS INC · prev qtr: $27.20M
- LIVN LIVANOVA PLC · prev qtr: $26.80M
- EMBC EMBECTA CORP · prev qtr: $16.33M
- ABVX ABIVAX SA · prev qtr: $15.12M
- HAE HAEMONETICS CORP/MASS · prev qtr: $12.44M
- TFX TELEFLEX INC · prev qtr: $11.34M
- BMRN BIOMARIN PHARMACEUTICAL INC · prev qtr: $10.97M
- GPCR STRUCTURE THERAPEUTICS INC · prev qtr: $10.08M
Insider Transactions (Form 4)
Latest Sio Capital Management, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
Sio Capital Management, LLC, based in New York, NY, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 59 positions worth $604.29M in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).
Firm Snapshot
- Headquarters: NEW YORK, NY, United States
- SEC registration: 801-78021 (status: Approved), registered 2013-05-16
- Regulatory AUM (Form ADV): $1.29B as of 2026-03-18
- Client mix (by RAUM): pension and profit-sharing plans 53%, pooled investment vehicles 47%
- Manages 2 private funds, of which 2 hedge funds
- Website: siocapital.com
Portfolio Structure
- 59 positions · $604.29M reported value (Q2 2026)
- Top 10 holdings = 48.6% of reported value
- Largest position: AVR (ANTERIS TECHNOLOGIES GLOBAL COM) at 9.0%
- Average position size: $10.24M
Sector Tilt
- Health Care 86.6%
- Consumer Discretionary 6.4%
- Information Technology 3.1%
- (classified holdings cover 98% of value)
Quarterly Activity
- Q2 2026: 16 new, 10 added, 22 reduced, 33 exited
- 11 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
5.55M | $54.63M | 9.04% | Add | |
| 2 |
|
173.59K | $49.12M | 8.13% | Add | |
| 3 |
|
715.27K | $38.45M | 6.36% | Reduce | |
| 4 |
|
13.32M | $27.71M | 4.59% | New | |
| 5 |
|
301.82K | $23.85M | 3.95% | New | |
| 6 |
|
436.70K | $22.89M | 3.79% | Add | |
| 7 |
|
695.32K | $22.21M | 3.67% | Add | |
| 8 |
|
925.83K | $19.01M | 3.15% | Reduce | |
| 9 |
|
1.23M | $18.17M | 3.01% | New | |
| 10 |
|
480.38K | $17.90M | 2.96% | New | |
| 11 |
|
177.12K | $16.86M | 2.79% | Add | |
| 12 |
|
57.75K | $15.92M | 2.63% | New | |
| 13 |
|
364.20K | $15.54M | 2.57% | Add | |
| 14 |
|
88.19K | $15.32M | 2.54% | Reduce | |
| 15 |
|
954.30K | $15.15M | 2.51% | New | |
| 16 |
|
1.10M | $14.51M | 2.40% | Hold | |
| 17 |
|
307.66K | $12.82M | 2.12% | Reduce | |
| 18 |
|
128.66K | $11.67M | 1.93% | Reduce | |
| 19 |
|
110.02K | $11.51M | 1.91% | Reduce | |
| 20 |
|
131.44K | $11.32M | 1.87% | Add | |
| 21 |
|
18.00K | $11.22M | 1.86% | New | |
| 22 |
|
193.50K | $11.15M | 1.84% | New | |
| 23 |
|
142.50K | $11.15M | 1.84% | New | |
| 24 |
|
1.08M | $10.96M | 1.81% | Reduce | |
| 25 |
|
1.59M | $9.05M | 1.50% | Add | |
| 26 |
|
623.13K | $8.91M | 1.48% | Reduce | |
| 27 |
|
1.30M | $8.59M | 1.42% | New | |
| 28 |
|
97.31K | $8.05M | 1.33% | Reduce | |
| 29 |
|
1.92M | $7.34M | 1.22% | Reduce | |
| 30 |
|
1.00M | $6.94M | 1.15% | Add | |
| 31 |
|
208.50K | $6.52M | 1.08% | New | |
| 32 |
|
1.49M | $6.18M | 1.02% | Reduce | |
| 33 |
|
59.25K | $5.78M | 0.96% | Reduce | |
| 34 |
|
127.81K | $5.62M | 0.93% | Reduce | |
| 35 |
|
539.49K | $5.30M | 0.88% | Reduce | |
| 36 |
|
208.56K | $5.29M | 0.88% | Reduce | |
| 37 |
|
73.95K | $5.19M | 0.86% | Reduce | |
| 38 |
|
1.08M | $4.92M | 0.81% | Hold | |
| 39 |
|
617.67K | $3.80M | 0.63% | Add | |
| 40 |
|
2.63M | $3.53M | 0.58% | Reduce | |
| 41 |
|
369.04K | $3.16M | 0.52% | New | |
| 42 |
|
1.01M | $2.70M | 0.45% | Reduce | |
| 43 |
|
124.17K | $2.63M | 0.43% | Reduce | |
| 44 |
|
75.00K | $2.60M | 0.43% | New | |
| 45 |
|
529.93K | $2.56M | 0.42% | Reduce | |
| 46 |
|
1.00M | $1.94M | 0.32% | Hold | |
| 47 |
|
327.24K | $1.89M | 0.31% | Hold | |
| 48 |
|
904.27K | $1.58M | 0.26% | Hold | |
| 49 |
|
152.46K | $1.46M | 0.24% | Hold | |
| 50 |
|
48.48K | $1.09M | 0.18% | New | |
Loading forecast…
Holdings Prediction Model
Predicts next-quarter Top-10 holdings and weights from the fund's own historical trading轨迹 (add / reduce / hold) plus each stock's price momentum and relative volume. Strictly no look-ahead: a prediction for quarter T+1 uses only data through quarter T. Weights are shares of the modelled portfolio.
The next-quarter predicted Top 10 (2026-Q3) is shown in the «Latest Q · Forecast» tab above, in the same holdings format. That view is for logged-in accounts: 3 views per day on Free, unlimited on Gold/Diamond.
Latest-Quarter Accuracy (2026-Q2)
P 50% R 50% F1 50% (modelled on 2026-Q1; 5/10 hit)
Historical Backtest (10 quarters)
Avg precision 46% · recall 46% · F1 46% · avg rank error 4.0 · Top-10 turnover 54%
| Quarter | Prec. | Recall | F1 | Predicted Top 10 | Actual Top 10 |
|---|---|---|---|---|---|
| 2024-Q1 | 50% | 50% | 50% | MRTX · GRCL · CI · LH · GMED · INSM · GSK · IMGN · UTHR · EMBC | LH · INSM · CI · GMED · MDGL · GSK · ZBH · MDT · OGN · TYRA |
| 2024-Q2 | 50% | 50% | 50% | LH · INSM · CI · GMED · MDGL · GSK · ZBH · MDT · TYRA · OGN | INSM · LH · TFX · ZBH · SNN · PCRX · OGN · GSK · CRBP · VXRT |
| 2024-Q3 | 40% | 40% | 40% | INSM · LH · TFX · ZBH · PCRX · SNN · OGN · GSK · CRBP · TYRA | LH · ISRG · TEVA · MMS · ZBH · VXRT · KVUE · TFX · TYRA · IRON |
| 2024-Q4 | 40% | 40% | 40% | LH · ISRG · TEVA · ZBH · MMS · VXRT · TFX · KVUE · TYRA · IRON | ICLR · MMS · CI · LH · SNY · ZBH · DRUG · AVR · ANNX · TFX |
| 2025-Q1 | 60% | 60% | 60% | ICLR · MMS · CI · LH · ZBH · SNY · DRUG · ANNX · AVR · TFX | ICLR · MMS · MRK · ZBH · NBIX · LH · DRUG · GMED · TFX · EMBC |
| 2025-Q2 | 50% | 50% | 50% | MMS · ICLR · MRK · ZBH · NBIX · DRUG · LH · TFX · EMBC · GMED | MMS · IRON · GMED · CNC · MRK · DRUG · NBIX · BMRN · ANNX · IDXX |
| 2025-Q3 | 40% | 40% | 40% | MMS · IRON · CNC · GMED · BMRN · DRUG · MRK · NBIX · ANNX · IDXX | MMS · CELC · SNY · DNTH · ALKS · IRON · MRK · HSIC · CNC · KVUE |
| 2025-Q4 | 40% | 40% | 40% | MMS · CELC · SNY · DNTH · IRON · ALKS · CNC · KVUE · HSIC · MRK | CELC · CI · SNY · MMS · ZBH · RYTM · KVUE · OGN · ICLR · WAY |
| 2026-Q1 | 40% | 40% | 40% | CI · SNY · CELC · MMS · ZBH · KVUE · RYTM · OGN · ICLR · DNTH | MMS · WAY · ICLR · COR · DNTH · AVR · CORT · LIVN · TYRA · CELC |
| 2026-Q2 ★ | 50% | 50% | 50% | MMS · WAY · ICLR · COR · AVR · DNTH · LIVN · CORT · TYRA · ANIP | AVR · COR · MMS · ALLO · GMED · GSK · TYRA · WAY · SLS · IDYA |
★ = latest filed quarter (predicted vs actual). Recall = share of the real Top 10 caught by the model; precision = share of the predicted Top 10 that were real.
FAQ
What did Sio Capital Management, LLC buy in 2026-Q2?
In its 2026-Q2 13F filing, Sio Capital Management, LLC reported 59 equity positions worth $604.29M in aggregate; its largest disclosed positions were AVR ($54.63M), COR ($49.12M), MMS ($38.45M).
How large is Sio Capital Management, LLC's portfolio?
Sio Capital Management, LLC reported $604.29M of long equity holdings across 59 positions as of 2026-Q2. Top-10 holdings account for 48.6% of reported value.
What is Sio Capital Management, LLC's investment style?
HoldingsHub classifies the portfolio as Small / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.